Cryogenic Blunt Dissection for Targeted Temporal Nerve Cooling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic pain and cosmetic defects, such as wrinkles and cellulite, often involve invasive procedures, systemic side effects, and temporary results, while existing cryogenic techniques face challenges in temperature control and target tissue accuracy.
Innovation Solution
The use of a cryogenic probe with a distal tip for blunt dissection and cooling treatment zones along tissue layers, allowing precise remodeling of target tissues like nerves and muscles, minimizing collateral damage and invasiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (pharmaceuticals, neurostimulators, neurolysis) are used for chronic pain, then pain relief is achieved, but systemic side effects and invasiveness increase
Solution Approach 1:
The cryogenic probe applies localized cooling directly to the target nerve or tissue, creating a focused treatment zone that eliminates pain without affecting other body systems. This localized approach replaces the systemic side effects of pharmaceuticals with a targeted physical treatment.
Solution Approach 2:
The invention replaces pharmacological and electrical treatment systems with a cryogenic cooling system. By using extreme cold to disrupt nerve conduction and promote tissue remodeling, the system achieves pain relief without the need for addictive opioids or systemic medications.
2Reliability
If invasive procedures (surgical implantation, nerve damage) are used for pain treatment, then pain relief is achieved, but recovery time and risk increase
Solution Approach 1:
The cryogenic treatment is applied in controlled periodic cycles, allowing the tissue to undergo gradual freezing and thawing processes that promote healing. This periodic application enables pain relief while minimizing tissue damage and reducing recovery time compared to surgical interventions.
Solution Approach 2:
The invention changes the physical parameter of temperature to achieve therapeutic effects. By controlling the temperature to reach subzero levels locally, the system creates a non-invasive treatment that avoids surgical risks and reduces recovery time while maintaining effective pain relief.
3Temperature
If cryogenic cooling is applied to treat tissue, then temperature control is achieved, but target tissue accuracy and collateral damage control are challenging
Solution Approach 1:
The cryogenic probe acts as an intermediary device that delivers controlled cooling from the treatment source to the target tissue. The probe's design includes insulation and positioning features that ensure accurate delivery of cold to the intended target while protecting surrounding tissues from collateral damage.
Solution Approach 2:
The system incorporates temperature monitoring and control mechanisms that provide feedback during the cryogenic treatment. This feedback allows real-time adjustment of cooling intensity to maintain precise temperature control and ensure accurate targeting of the intended tissue while preventing excessive cooling of adjacent structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides controlled, precise cosmetic and therapeutic effects with reduced recovery time and systemic side effects, offering alternatives to pharmacological and invasive treatments.
Implementation Method 1
applying cryogenic cooling to dermatological tissues so as to selectively remodel one or more target tissues
Implementation Method 2
the use of energy to cause a thermal injury to the nerves such as via the application of radiofrequency ('RF') energy to achieve ablation
Data Source
AI summary
A point of incision is created within tissue, the tissue having a temporoparietal fascia-deep temporoparietal fascia layer (TPF-sDTF) beneath skin and a temporal branch of a target nerve extending along a portion of the TPF-sDTF, the point of incision being laterally displaced from the target nerve. A cryogenic probe having a distal tip extending from an elongated body is inserted into the point of incision. The TPF-sDTF is bluntly dissected using the cryogenic probe such that a treating portion of the cryogenic probe is directly adjacent to a first treatment portion of the target nerve. The cryogenic probe is activated to create a first treatment zone at the first treatment portion of the target nerve to cause a therapeutic effect.


